Investor
The funds will be used to advance Insilico's drug pipeline and lab, which automates the research and development process, and refine its AI-enabled models and algorithms.
The funds will be used to expand the U.S. and European reach of its FDA-cleared tinnitus treatment device, Lenire, including with the Department of Veterans Affairs.
The San Francisco-based digital musculoskeletal care company filed to go public on Monday and will list under the ticker symbol HNGE.
The MSK company will use the funds to expand its value-based care initiatives and advance its technology and clinical programs.
It is also expected to offer a new digital weight loss program.
The New York-based company also reported a 110% increase in fourth-quarter revenue in 2024 compared to Q4 2023 and a Q4 2024 net loss of $9.6 million.
Leaders of government public policy at HIMSS are prioritizing health equity, AI regulation, cybersecurity and workforce development while urging unified policies that support healthcare innovation.
Upcoming features include pre-chart summary creation.
HIMSS25
HIMSS editors recap the sessions they attended on day 3 of HIMSS25, which included questions about government support of telehealth and how interoperability and data exchange will proceed under the new administration.
Punit Singh Soni, founder and CEO of Suki, joined MobiHealthNews at HIMSS25 to discuss its experience over the years at the conference as the company has grown.